Axsome Therapeutics, Inc. revenue breakdown overview

Axsome Therapeutics, Inc. revenue for the last year amounted to 270.60 M USD, the most of which — 270.60 M USD — came from its highest performing source at the moment, Novel Therapies, the year earlier bringing 50.04 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Axsome Therapeutics, Inc. 197.22 M USD, and the year before that — 50.04 M USD.